Citation Impact
Citing Papers
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of asthma in adults: Fig 1
1996
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Efficacy, Safety, and Effects on Quality of Life of Salmeterol Versus Albuterol in Patients with Mild to Moderate Persistent Asthma
1998
Consensus statement * on the treatment of allergic rhinitis
2000
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
2003
Leukotriene-receptor antagonists
1999
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
1998
High-dose Inhaled Albuterol in Severe Chronic Airflow Limitation
1988
Azelastine Nasal Spray as Adjunctive Therapy to Azelastine Tablets in the Management of Seasonal Allergic Rhinitis
1997
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma
2005
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
1997
Loratadine‐pseudoephedrine in children with allergic rhinitis, a controlled double‐blind trial
1998
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
2005
Exposure to an Aeroallergen as a Possible Precipitating Factor in Respiratory Arrest in Young Patients with Asthma
1991 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic Asthma<subtitle>A Multicenter, Randomized, Double-blind Trial</subtitle>
1998
Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis
1995
Intranasal Azelastine
1998
Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study
2001
Loratadine
1989
Intranasal steroids and the risk of emergency department visits for asthma
2002
The impact of allergic rhinitis on bronchial asthma
1998
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
1998
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Intranasal Fluticasone Propionate
1992
Inhaled beclomethasone versus placebo for chronic asthma
1999
Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
1995
Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy
2001
CURRENT THOUGHTS REGARDING TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
1996
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children
2000
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids
2005
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Leukotriene antagonism in asthma and rhinitis
1998
Lung Deposition of Hydrofluoroalkane-134a Beclomethasone Is Greater Than That of Chlorofluorocarbon Fluticasone and Chlorofluorocarbon Beclomethasone
2002
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
1999
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study
2004
Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma
2004
Asthma
1992
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
IgE and mast cells in allergic disease
2012 Standout
Standardisation of spirometry
2005 Standout
Mometasone Furoate
1998
Current concepts and therapeutic strategies forallergic rhinitis in school-age children
2004
Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review
2004
β-Adrenergic Bronchodilators
1995
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
2000
Respiratory Arrest in near-Fatal Asthma
1991 Standout
Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis
1996
A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma
2001
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
1999
Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators
1998
Mortality from asthma, 1979–1984
1988
Optimal asthma control, starting with high doses of inhaled budesonide
2000
Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
1997
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma
2007
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study
1995
The Pharmacology and Use of H1-Receptor-Antagonist Drugs
1994
Asthma
2017 Standout
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
2003
A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler
1997
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
2003
Influence of body mass index on the response to asthma controller agents
2006
Effect of Omalizumab on Symptoms of Seasonal Allergic Rhinitis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness
1999
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Long-Acting β<SUB>2</SUB>-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Long-acting ?2-agonists in management of childhood asthma: A critical review of the literature
2000
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist
1998
Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma
1994
Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: A placebo-controlled, double-blind study
1995
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Inhaled and nasal corticosteroids Factors affecting the risks of systemic adverse effects
1999
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
2003
Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis
2001
The development of allergic inflammation
2008 StandoutNature
Circadian control of the immune system
2013 Standout
Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids
2000
Triamcinolone Acetonide
1997
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
2005
DIAGNOSIS AND MANAGEMENT OF STEROID-RESISTANT ASTHMA
1997
Role of histamine in the pathophysiology of asthma: immunomodulatory and anti-inflammatory activities of H1-receptor antagonists
2002
Asthma
2001 Standout
Fluticasone at different doses for chronic asthma in adults and children
2005
The antihistamines of the nineties
1993
Inhaled and nasal corticosteroids: safety aspects*
2000
Neurobiology of Depression
2002 Standout
Brompheniramine, Loratadine, and Placebo in Allergic Rhinitis: A Placebo‐Controlled Comparative Clinical Trial
1998
Changes in skin‐test reactivity do not correlate with clinical efficacy of H1‐blockers in seasonal allergic rhinitis
1998
Loratadine
1993
The organization and consequences of eicosanoid signaling
2003
Quality of life changes in COPD patients treated with salmeterol.
1997
Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis
1998
Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor
1999
Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind, Placebo-Controlled Trial
2004
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
SF-36 Health Survey Update
2000 Standout
The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis
1999
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial
2001
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
A double blind comparison of intranasal budesonide 400 ?g and 800 ?g in perennial rhinitis
1992
The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines
2008
The ??2-Agonist Controversy
1994
Relationships between rhinitis and asthma
1998
A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis
1996
The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
2003
Efficacy and Safety of Triamcinolone Acetonide Aqueous Nasal Spray in Patients with Seasonal Allergic Rhinitis
1996
Reduction of Eosinophilic Inflammation in the Airways of Patients With Asthma Using Montelukast
2002
Safety and Efficacy of Azelastine Nasal Spray (Astelin NS) for Seasonal Allergic Rhinitis: a 4-Week Comparative Multicenter Trial
1996
Biaryl Phosphane Ligands in Palladium‐Catalyzed Amination
2008 Standout
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Glucocorticoid-induced osteoporosis
2000
Fluticasone Propionate Improves Quality of Life in Patients with Asthma Requiring Oral Corticosteroids
1996
Regulation of Adrenergic Receptor Responsiveness Through Modulation of Receptor Gene Expression
1991 StandoutNobel
Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis
1995
Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild Asthma
1996
Risk-Benefit Assessment of Fluticasone Propionate in the Treatment of Asthma and Allergic Rhinitis
1998
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
2000
Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis
2000
Allergic rhinobronchitis: The asthma–allergic rhinitis link
1999
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
1994
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma
2006
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
2003
Allergic rhinitis: An update on disease, present treatments and future prospects
2011
Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma Receiving Salmeterol<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
1997
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Anti‐immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti‐inflammatory activity and clinical efficacy
2005
A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis
2002
Second-Generation Antihistamines
1999
Adherence to Medication
2005 Standout
Asthma
2000 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Severe Asthma in Adults
2005
Combination Therapy with a Long-Acting β-Agonist and a Leukotriene Antagonist in Moderate Asthma
2006
Can Guideline-defined Asthma Control Be Achieved?
2004
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
Asthma
2005
Choosing a Long-term Controller Medication in Childhood Asthma
1997
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Sedation and Performance Issues in the Treatment of Allergic Conditions
1997
Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist
2002
Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
2001
Iron Catalysis in Organic Synthesis
2015 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Adrenergic therapy of bronchial asthma
1986
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
2003
High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children
2004
Magnesium in Man: Implications for Health and Disease
2014 Standout
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma
2004
Absence of Growth Retardation in Children With Perennial Allergic Rhinitis After One Year of Treatment With Mometasone Furoate Aqueous Nasal Spray
2000
Beclomethasone for asthma in children: effects on linear growth
1999
Long- and Short-Acting ß2-Adrenergic Agonists
1996
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
1998 StandoutScience
Tri-Nasal Triamcinolone Acetonide Nasal Spray 200 and 400 μg qd versus Placebo and Nasacort Triamcinolone Acetonide Nasal Aerosol 440 μg qd in Patients Suffering from Seasonal Allergic Rhinitis during the Grass Season
1998
Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study
2005
H1-Receptor Antagonists
1994
Oral Montelukast Versus Inhaled Beclomethasone in 6- to 11-year-old Children with Asthma: Results of an Open-label Extension Study Evaluating Long-term Safety, Satisfaction, and Adherence with Therapy
2001
Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials
2000
Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal Glucocorticoid for Allergic Rhinitis
1997
Iron catalyzed enantioselective sulfa-Michael addition: a four-step synthesis of the anti-asthma agent Montelukast
2014
In Vitro Desensitization of Beta Adrenergic Receptors in Human Neutrophils. ATTENUATION BY CORTICOSTEROIDS
1983 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The organization and consequences of eicosanoid signaling
2003
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Volume Adjustment of Maximal Midexpiratory Flow
1980
Immunotherapy as an effective tool in allergy treatment
1998
Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years
2001
Tachyphylaxis to inhaled isoproterenol and the effect of methylprednisolone in dogs
1980
Effect of Acupuncture in the Treatment of Seasonal Allergic Rhinitis: A Randomized Controlled Clinical Trial
2002
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial
1999
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Interventions for enhancing medication adherence
2014 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors
2013 StandoutNobel
Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma
1999
Fluticasone at different doses for chronic asthma in adults and children
2008
The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis
1998
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
2000
Inhibition of Cytosolic Phospholipase A2α: Hit to Lead Optimization
2005
Anticholinergic therapy for chronic asthma in children over two years of age
2003
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis
2003
Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells
2001
Ipratropium Bromide Nasal Spray 0.03% Provides Additional Relief from Rhinorrhea When Combined With Terfenadine in Perennial Rhinitis Patients; A Randomized, Double-Blind, Active-Controlled Trial
1998
Intranasal Fluticasone Propionate
1997
Works of Paul Chervinsky being referenced
SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis
1989
A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma
1992
Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma
1997
Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.
1995
Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis
1999
The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control
1997
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge
2004
Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis
1996
Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis
1996
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
1994
A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray
1996
Dose-Related Response to Inhaled Fluticasone Propionate in Patients with Methacholine-Induced Bronchial Hyperresponsiveness: A Double-Blind, Placebo-Controlled Study
1998
Effects of montelukast and beclomethasone on airway function and asthma control
2002
Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma
1996
A One-Week Dose-Ranging Study of Inhaled Salmeterol in Children with Asthma
1997
Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma
1999
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
1998
Fluticasone Propionate HFA-134a Pressurized Metered-Dose Inhaler in Adolescents and Adults with Moderate to Severe Asthma
2005
Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
1997
Dose Ranging Study of Mometasone Furoate (Nasonex) in Seasonal Allergic Rhinitis
1997
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
2003
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group
1998
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma
1999
Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate Asthma
1999
Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma
1999
Efficacy of Inhaled Fluticasone Propionate in Asthma Results from Topical and Not from Systemic Activity
1997
A Comparison of Loratadine, a New Nonsedating Antihistamine, with Clemastine and Placebo in Patients with Fall Seasonal Allergic Rhinitis
1987
464 Fluticasone propionate (FP) aerosol in asthma
1991
Comparison of inhaled albuterol powder and aerosol in asthma
1987
Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring
1984
Comparison of metaproterenol and isoproterenol aerosols: spirometric evaluation after two months' therapy.
1969
Once daily loratadine versus astemizole once daily.
1994
Effectiveness of Azelastine Nasal Solution in Seasonal Allergic Rhinitis
1994
Concomitant bronchodilator therapy and ipratropium bromide: A clinical review
1986
Beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma
1976
Treatment of seasonal allergic rhinitis with long-acting steroid injections. A comparison of four preparations.
1968
63 Intranasal fluticasone propionate (FP) is more effective than loratadine (LOR) for treatment of seasonal allergic rhinitis symptoms
1996
Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis.
1990
Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group.
1996
Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator
1977
61 Fluticasone propionate once daily is as effective as beclomethasone dipropionate twice daily for perennial allergic rhinitis
1991
Adverse effects and complications of treatment with beta-adrenergic agonist drugs
1985
Safety of salmeterol in the maintenance treatment of asthma.
1995
Detection of Growth Suppression in Children During Treatment With Intranasal Beclomethasone Dipropionate
2000
Efficacy and Safety of Triamcinolone Acetonide Aerosol in Chronic Asthma
1982